Cosmos Health (NASDAQ:COSM) CEO Acquires $176,660.50 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 353,321 shares of the business’s stock in a transaction dated Tuesday, January 20th. The shares were bought at an average price of $0.50 per share, for a total transaction of $176,660.50. Following the completion of the acquisition, the chief executive officer owned 8,091,795 shares in the company, valued at approximately $4,045,897.50. This trade represents a 4.57% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, January 14th, Grigorios Siokas bought 493,495 shares of Cosmos Health stock. The stock was bought at an average price of $0.45 per share, with a total value of $222,072.75.
• On Monday, January 12th, Grigorios Siokas purchased 113,185 shares of Cosmos Health stock. The shares were bought at an average cost of $0.50 per share, with a total value of $56,592.50.
• On Thursday, January 8th, Grigorios Siokas purchased 156,190 shares of Cosmos Health stock. The stock was bought at an average price of $0.52 per share, for a total transaction of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas acquired 124,880 shares of Cosmos Health stock. The shares were bought at an average cost of $0.52 per share, with a total value of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas acquired 133,953 shares of Cosmos Health stock. The shares were purchased at an average price of $0.54 per share, with a total value of $72,334.62.
• On Friday, December 19th, Grigorios Siokas bought 88,314 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.49 per share, for a total transaction of $43,273.86.
• On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.42 per share, with a total value of $70,758.24.
• On Friday, November 28th, Grigorios Siokas purchased 76,360 shares of Cosmos Health stock. The shares were purchased at an average price of $0.64 per share, with a total value of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas acquired 55,732 shares of Cosmos Health stock. The stock was purchased at an average price of $0.63 per share, for a total transaction of $35,111.16.
• On Friday, November 21st, Grigorios Siokas acquired 56,080 shares of Cosmos Health stock. The stock was purchased at an average cost of $0.68 per share, for a total transaction of $38,134.40.

Cosmos Health Stock Down 1.6%

Shares of NASDAQ:COSM opened at $0.50 on Friday. The stock has a 50-day simple moving average of $0.53 and a 200-day simple moving average of $0.73. The stock has a market capitalization of $18.65 million, a P/E ratio of -0.66 and a beta of 5.37. Cosmos Health Inc. has a 1 year low of $0.28 and a 1 year high of $1.32. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.84 and a current ratio of 0.99.

Cosmos Health (NASDAQ:COSM) last posted its quarterly earnings results on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.16). Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. The business had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Equities analysts forecast that Cosmos Health Inc. will post -0.78 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC increased its position in Cosmos Health Inc. (NASDAQ:COSM) by 133.1% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the period. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 at the end of the most recent reporting period. 12.61% of the stock is currently owned by institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.